Regional expansion Panpharma is actively investing to modernize and expand production capacity in Luitré-Dompierre, France and Trittau, Germany, signaling growth in European injectable antibiotic, anesthetic, and analgesic portfolios and creating cross-border supply opportunities.

Hospital focus The company specializes in injectable generics for hospitals and clinics across France and 75+ countries, presenting aligned demand channels for hospital formulary access, IV antibiotic supply, and critical care analgesics.

Manufacturing scale With a multi-site production footprint in France and Germany and a plan to invest tens of millions, Panpharma can support large-volume contracts, tender participation, and ongoing supply reliability for essential medicines.

Sustainability angle As a responsible lab with a long-term vision, Panpharma’s investment in modernized, secure production facilities can be leveraged in sustainability-minded procurement conversations around quality, compliance, and risk reduction.

Growth potential Revenue range and existing export footprint across 75 countries suggest opportunities for partnerships in regional distributors, contract manufacturing, and supply chain collaboration to accelerate market access for generic injectable portfolios.